iBio activates sterile fill-finish operations for clinical stage biopharma 27-Jun-2019 By Maggie Lynch Sterile fill-finish capabilities will be available to clinical stage customers as iBio activates its operations for biopharmaceutical products after entering a supply agreement.
Rexgenero extends European reach with expanded manufacturing 29-May-2019 By Maggie Lynch Partnership with German Red Cross will see Rexgenero’s lead drug candidate reaching broader patient base in clinical trials.
Abzena creates offering for drug candidate optimization 29-Mar-2019 By Maggie Lynch Abzena launches a developability assessment and optimization service to assist customers in selecting and developing lead candidates for manufacture.
Merck extends research agreement for NASH drug candidate 27-Mar-2019 By Maggie Lynch Merck exercises its option to extend research phase with NGM for an additional two-year period, moving the collaboration end date to March 2022.
